Infan Industria Quimica Farmaceutica Nacional
Quick facts
Phase 3 pipeline
- Oral Aroeira · Psychiatry
Oral Aroeira is a small molecule that targets the serotonin receptor.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Infan Industria Quimica Farmaceutica Nacional portfolio CI brief
- Infan Industria Quimica Farmaceutica Nacional pipeline updates RSS
Frequently asked questions about Infan Industria Quimica Farmaceutica Nacional
What is Infan Industria Quimica Farmaceutica Nacional's pipeline?
Infan Industria Quimica Farmaceutica Nacional has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Oral Aroeira.
Related
- Sector hub: All tracked pharma companies